The use of atypical antipsychotics after traumatic brain injury

Journal of Head Trauma Rehabilitation

Volumn 23, Issue 2, 2008, Pages 132-135

  Elovic, Elie Paul ^a   Jasey Jr , Neil N ^b   Eisenberg, Michal E ^b  

^a KESSLER FOUNDATION   (United States)

^b NONE

Author keywords

Agitation; Aripiprazole; Atypical antipsychotic; Behavior; Clozapine; Olanzapine; Quetiapine; Risperidone; Traumatic brain injury; Ziprasidone

Indexed keywords

ARIPIPRAZOLE; CLOZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

AGGRESSION; AGITATION; AGRANULOCYTOSIS; APLASTIC ANEMIA; CATARACT; CLINICAL TRIAL; COGNITION; DIABETES MELLITUS; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; EXTRAPYRAMIDAL SYNDROME; GLUCOSE INTOLERANCE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERPROLACTINEMIA; MORTALITY; NEUROPROTECTION; NONHUMAN; ORTHOSTATIC HYPOTENSION; PATIENT COMPLIANCE; PSYCHOSIS; QT PROLONGATION; RECEPTOR BINDING; RESTLESSNESS; REVIEW; RISK ASSESSMENT; SCHIZOPHRENIA; SEDATION; SEIZURE; SIDE EFFECT; SLEEP DISORDER; TRAUMATIC BRAIN INJURY; WEIGHT GAIN;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BRAIN INJURIES; CLOZAPINE; DIBENZOTHIAZEPINES; HUMANS; PIPERAZINES; PSYCHOMOTOR AGITATION; QUINOLONES; RISPERIDONE; THIAZOLES;

EID: 41149086901     PISSN: 08859701     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.HTR.0000314532.07530.e5     Document Type: Review

References (23)

1. Elovic EP, Lansang R, Li Y, Ricker JH. The use of atypical antipsychotics in traumatic brain injury. J Head Trauma Rehabil. 2003;18:177-195.
2. Goldstein LB. Common drugs may influence motor recovery after stroke. The Sygen in Acute Stroke Study Investigators. Neurology. 1995;45:865-871.
3. Arciniegas DB, Harris SN, Brousseau KM. Psychosis following traumatic brain injury. Int Rev Psychiatry. 2003;15:328-340.
4. Gardner DM, Baldessarini RJ, Waraich P. Modern antipsychotic drugs: a critical overview. Can Med Assoc J. 2005;172:1703-1711.
5. Horacek J, Bubenikova-Valesova V, Kopecek M, et al. Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia. CNS Drugs. 2006;20:389-409.
6. Stahl S. Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 2nd ed. New York: Cambridge University Press; 2000.
7. 1A receptor activation. Brain Res. 2005;1043:32-41.
8. Kurosawa S, Hashimoto E, Ukai W, Toki S, Saito S, Saito T. Olanzapine potentiates neuronal survival and neural stem cell differentiation: regulation of endoplasmic reticulum stress response proteins. J Neural Transm. 2007;114:1121-1128.
9. Michals ML, Crismon ML, Roberts S, Childs A. Clozapine response and adverse effects in nine brain-injured patients. J Clin Psychopharmacol. 1993;13:198-203.
10. Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs. 2005;19(suppl 1):1-93.
11. Silver BV, Collins L, Zidek KA. Risperidone treatment of motor restlessness following anoxic brain injury. Brain Inj. 2003;17:237-244.
12. Schreiber S, Klag E, Gross Y, Segman RH, Pick CG. Beneficial effect of risperidone on sleep disturbance and psychosis following traumatic brain injury. Int Clin Psychopharmacol. 1998;13:273-275.
13. Mizoguchi Y, Monji A, Isayama H, Tashiro N. Risperidone and refusal to eat after traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2002;14:87-88.
14. Oster TJ, Anderson CA, Filley CM, Wortzel HS, Arciniegas DB. Quetiapine for mania due to traumatic brain injury. CNS Spectr. 2007;12:764-769.
15. Kim E, Bijlani M. A pilot study of quetiapine treatment of aggression due to traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2006;18:547-549.
16. Tahir R. Metabolic effects of atypical antipsychotics. US Pharm. 2007;32:HS3-HS14.
17. Noe E, Ferri J, Trenor C, Chirivella J. Efficacy of ziprasidone in controlling agitation during post-traumatic amnesia. Behav Neurol. 2007;18:7-11.
18. Alderfer BS, Arciniegas DB. Treatment of intractable hiccups with olanzapine following recent severe traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2006;18:551-552.
19. Kivircik Akdede BB, Alptekin K, Kitis A, Arkar H, Akvardar Y. Effects of quetiapine on cognitive functions in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:233-238.
20. McGurk SR, Lee MA, Jayathilake K, Meltzer HY. Cognitive effects of olanzapine treatment in schizophrenia. Med Gen Med. 2004;6:27.
21. Weiser M, Shneider-Beeri M, Nakash N, et al. Improvement in cognition associated with novel antipsychotic drugs: a direct drug effect or reduction of EPS? Schizophr Res. 2000;46:81-89.
22. Jeste DV, Blazer D, Casey D, et al. ACNP white paper: update on use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology. 2007.
23. US Food and Drug Administration. Deaths with antipsychotics in elderly patients with behavioral disturbances. 2005. http://www.fda.gov/cder/drug/ advisory/antipsychotics.htm. Accessed January 12, 2008.